31 December 2014 in Academic Emergency Medicine
1 May 2007 in The American Journal of Emergency Medicine
1 July 2013 in Respiratory Care
BACKGROUND: Measuring and monitoring end-tidal carbon dioxide (PETCO2) is an important aspect of caring for critically ill patients. The 2 methods used for PETCO2 measurement are the mainstream and sidestream methods. OBJECTIVE: To assess the agreement between PETCO2 measurements performed by mainstream and sidestream methods with the PaCO2 values. METHODS: This was a prospective observational study. A total of 114 subjects were enrolled in the study. PETCO2 measurements using mainstream and sidestream methods were performed simultaneously with the arterial blood sampling in subjects who were observed in the emergency department and required arterial blood gas analysis. Agreement between the PETCO2 measurements and the PaCO2 values obtained from arterial blood gas analysis were evaluated using the Bland-Altman method. RESULTS: Sixty subjects (52.6%) were female, and the mean age was 60.9 years (95% CI 58.3–63.6). The mean PaCO2 was 35.16 mm Hg (95% CI 33.81–36.51), the mainstream PETCO2 was 22.11 (95% CI 21.05–23.18), and the sidestream PETCO2 was 25.48 (95% CI 24.22–26.75). Bland-Altman analysis showed an average difference between mainstream PETCO2 and PaCO2 values of 13 mm Hg (95% limits of agreement −0.6 to 25.5) and moderate correlation (r = 0.55, P < .001). The average difference between the sidestream PETCO2 and PaCO2 values was 9.7 mm Hg (95% limits of agreement −5.4 to 24.7) and poor correlation (r = 0.41, P < .001). CONCLUSIONS: PETCO2 values obtained by mainstream and sidestream methods were found to be significantly lower than the PaCO2 values. There was essentially no agreement between the measurements obtained by 2 different methods and the PaCO2 values.
3 February 2011 in Blood Pressure
Objective. Anxiety is an important cause of acute blood pressure (BP) elevation. However, the role of anxiolysis in this situation is still controversial. In this study, the relationship of anxiety with BP and the effect of anxiolytic treatment on BP were investigated. Methods. Emergency department (ED) patients with an initial systolic BP (SBP) ≥ 160 mmHg or diastolic BP (DBP) ≥ 100 mmHg but no end organ damage were approached for inclusion in the study. In those consenting to participate, anxiety levels were measured using the State-Trait Anxiety Index (STAI) and Visual Analog Scale for Anxiety (VAS-A). Patients were randomly assigned to receive oral alprazolam 0.5 mg or captopril 25 mg. BP and anxiety levels were measured at baseline and at 1 and 2 h after administration of the study medication. Results. Of 133 patients meeting inclusion criteria, 53 patients agreed to participate. Of these, 27 patients (50.9%) received captopril and 26 patients (49.1%) received alprazolam. The majority of the patients had a high-level trait (96.2%, n = 51) and state anxiety (81.1%, n = 43). The mean SBP and VAS-A values of both patient groups dropped significantly over the 2 h, with no significant difference between the two groups. A significant association between SBP and VAS-A scores was found (F(2,50) = 6.27, p = 0.004). Conclusion: A significant association exists between the level of BP and anxiety in hypertensive ED patients. Alprazolam is as effective as captopril in lowering BP in ED patients with an initial SBP > 160 mmHg.
1 August 2007 in The Journal of Emergency Medicine
1 June 2017 in Annals of Emergency Medicine